These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
|
For the quarterly period ended
|
|||||
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
|
For the transition period from
to
.
|
|||||
|
||||||||
|
|
|
||||
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | ||||
| Securities Registered Pursuant to Section 12(b) of the Act: | ||||||||
| Title of Each Class | Trading Symbol(s) | Name of Each Exchange on which Registered | ||||||
|
|
|
|
||||||
|
|
☑ | Accelerated filer | ☐ | |||||||||||
| Non-accelerated filer | ☐ | Smaller reporting company |
|
|||||||||||
| Emerging growth company |
|
|||||||||||||
|
Third Quarter 2025 Form 10-Q
|
|
1
|
||||||
|
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS | |||||||
|
2
|
|
Third Quarter 2025 Form 10-Q
|
||||||
|
PART I. FINANCIAL INFORMATION | |||||||
|
Blackbaud, Inc.
Condensed Consolidated Balance Sheets (Unaudited) |
||||||||
| (dollars in thousands, except per share amounts) |
September 30,
2025 |
December 31,
2024 |
||||||
| Assets | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ |
|
$ |
|
||||
| Restricted cash |
|
|
||||||
|
Accounts receivable, net of allowance of $
|
|
|
||||||
| Customer funds receivable |
|
|
||||||
| Prepaid expenses and other current assets |
|
|
||||||
| Total current assets |
|
|
||||||
| Property and equipment, net |
|
|
||||||
| Operating lease right-of-use assets |
|
|
||||||
| Software development costs, net |
|
|
||||||
| Goodwill |
|
|
||||||
| Intangible assets, net |
|
|
||||||
| Other assets |
|
|
||||||
| Total assets | $ |
|
$ |
|
||||
| Liabilities and stockholders’ equity | ||||||||
| Current liabilities: | ||||||||
| Trade accounts payable | $ |
|
$ |
|
||||
| Accrued expenses and other current liabilities |
|
|
||||||
| Due to customers |
|
|
||||||
| Debt, current portion |
|
|
||||||
| Deferred revenue, current portion |
|
|
||||||
| Total current liabilities |
|
|
||||||
| Debt, net of current portion |
|
|
||||||
| Deferred tax liability |
|
|
||||||
| Deferred revenue, net of current portion |
|
|
||||||
| Operating lease liabilities, net of current portion |
|
|
||||||
| Other liabilities |
|
|
||||||
| Total liabilities |
|
|
||||||
| Commitments and contingencies (see Note 8) |
|
|
||||||
| Stockholders’ equity: | ||||||||
|
Preferred stock;
|
|
|
||||||
|
Common stock, $
|
|
|
||||||
| Additional paid-in capital |
|
|
||||||
|
Treasury stock, at cost;
|
(
|
(
|
||||||
| Accumulated other comprehensive loss |
(
|
(
|
||||||
| Accumulated deficit |
(
|
(
|
||||||
| Total stockholders’ equity |
|
|
||||||
| Total liabilities and stockholders’ equity | $ |
|
$ |
|
||||
| The accompanying notes are an integral part of these condensed consolidated financial statements. | ||||||||
|
Third Quarter 2025 Form 10-Q
|
|
3
|
||||||
|
Blackbaud, Inc.
Condensed Consolidated Statements of Comprehensive Income
(Unaudited)
|
|||||||||||||||||
| (dollars in thousands, except per share amounts) |
Three months ended
September 30, |
Nine months ended
September 30, |
|||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||
| Revenue | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||
| Cost of revenue |
|
|
|
|
|||||||||||||
| Gross profit |
|
|
|
|
|||||||||||||
| Operating expenses | |||||||||||||||||
| Sales, marketing and customer success |
|
|
|
|
|||||||||||||
| Research and development |
|
|
|
|
|||||||||||||
| General and administrative |
|
|
|
|
|||||||||||||
| Amortization of intangible assets |
|
|
|
|
|||||||||||||
| Total operating expenses |
|
|
|
|
|||||||||||||
| Income from operations |
|
|
|
|
|||||||||||||
| Interest expense |
(
|
(
|
(
|
(
|
|||||||||||||
| Other income, net |
|
|
|
|
|||||||||||||
| Income before (benefit) provision for income taxes |
|
|
|
|
|||||||||||||
| Income tax (benefit) provision |
(
|
|
|
|
|||||||||||||
| Net income | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||
| Earnings per share | |||||||||||||||||
| Basic | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||
| Diluted | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||
| Common shares and equivalents outstanding | |||||||||||||||||
| Basic weighted average shares |
|
|
|
|
|||||||||||||
| Diluted weighted average shares |
|
|
|
|
|||||||||||||
| Other comprehensive loss | |||||||||||||||||
| Foreign currency translation adjustment | $ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||
| Unrealized loss on derivative instruments, net of tax |
(
|
(
|
(
|
(
|
|||||||||||||
| Total other comprehensive loss |
(
|
(
|
(
|
(
|
|||||||||||||
| Comprehensive income | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||
| The accompanying notes are an integral part of these condensed consolidated financial statements. | |||||||||||||||||
|
4
|
|
Third Quarter 2025 Form 10-Q
|
||||||
|
Blackbaud, Inc.
Condensed Consolidated Statements of Cash Flows (Unaudited) |
||||||||
| (dollars in thousands) |
Nine months ended
September 30, |
|||||||
| 2025 | 2024 | |||||||
| Cash flows from operating activities | ||||||||
| Net income | $ |
|
$ |
|
||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
| Depreciation and amortization |
|
|
||||||
| Provision for credit losses and sales returns |
|
|
||||||
| Stock-based compensation expense |
|
|
||||||
| Deferred taxes |
(
|
(
|
||||||
| Amortization of deferred financing costs and discount |
|
|
||||||
| Loss on disposition of businesses |
|
|
||||||
| Other non-cash adjustments |
(
|
|
||||||
| Changes in operating assets and liabilities, net of acquisition and disposal of businesses: | ||||||||
| Accounts receivable |
(
|
|
||||||
| Prepaid expenses and other assets |
(
|
(
|
||||||
| Trade accounts payable |
(
|
|
||||||
| Accrued expenses and other liabilities |
|
(
|
||||||
| Deferred revenue |
|
|
||||||
| Net cash provided by operating activities |
|
|
||||||
| Cash flows from investing activities | ||||||||
| Purchase of property and equipment |
(
|
(
|
||||||
| Capitalized software development costs |
(
|
(
|
||||||
| Cash used in disposition of business |
(
|
(
|
||||||
| Other investing activities |
|
(
|
||||||
| Net cash used in investing activities |
(
|
(
|
||||||
| Cash flows from financing activities | ||||||||
| Proceeds from issuance of debt |
|
|
||||||
| Payments on debt |
(
|
(
|
||||||
| Debt issuance costs |
|
(
|
||||||
| Employee taxes paid for withheld shares upon equity award settlement |
(
|
(
|
||||||
| Change in due to customers |
(
|
(
|
||||||
| Change in customer funds receivable |
(
|
(
|
||||||
| Purchase of treasury stock, including excise tax payments |
(
|
(
|
||||||
| Net cash used in financing activities |
(
|
(
|
||||||
| Effect of exchange rate on cash, cash equivalents and restricted cash |
|
|
||||||
| Net decrease in cash, cash equivalents and restricted cash |
(
|
(
|
||||||
| Cash, cash equivalents and restricted cash, beginning of period |
|
|
||||||
| Cash, cash equivalents and restricted cash, end of period | $ |
|
$ |
|
||||
| (dollars in thousands) |
September 30,
2025 |
December 31,
2024 |
||||||
| Cash and cash equivalents | $ |
|
$ |
|
||||
| Restricted cash |
|
|
||||||
| Total cash, cash equivalents and restricted cash in the statement of cash flows | $ |
|
$ |
|
||||
| The accompanying notes are an integral part of these condensed consolidated financial statements. | ||||||||
|
Third Quarter 2025 Form 10-Q
|
|
5
|
||||||
| (dollars in thousands) | Common stock | Treasury stock |
Additional
paid-in capital |
Accumulated
other
comprehensive
loss
|
Accumulated deficit | Total stockholders' equity | ||||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | |||||||||||||||||||||||||||||
| Balance at December 31, 2024 |
|
$ |
|
(
|
$ |
(
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
||||||||||||||||||
| Net income | — | — | — | — | — | — |
|
|
||||||||||||||||||||||||
| Purchase of treasury shares under stock repurchase program, inclusive of excise tax | — | — |
(
|
(
|
|
— | — |
(
|
||||||||||||||||||||||||
| Vesting of restricted stock units |
|
— | — | — |
|
— | — |
|
||||||||||||||||||||||||
| Shares withheld to satisfy tax withholdings | — | — |
(
|
(
|
— | — | — |
(
|
||||||||||||||||||||||||
| Stock-based compensation | — | — | — | — |
|
— |
|
|
||||||||||||||||||||||||
| Restricted stock grants |
|
|
— | — | — | — | — |
|
||||||||||||||||||||||||
| Restricted stock cancellations |
(
|
— | — | — | — | — | — | — | ||||||||||||||||||||||||
| Other comprehensive loss | — | — | — | — | — |
(
|
— |
(
|
||||||||||||||||||||||||
| Balance at March 31, 2025 |
|
$ |
|
(
|
$ |
(
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
||||||||||||||||||
| Net income | — | — | — | — | — | — |
|
|
||||||||||||||||||||||||
| Purchase of treasury shares under stock repurchase program, inclusive of excise tax | — | — |
|
(
|
|
— | — |
(
|
||||||||||||||||||||||||
| Vesting of restricted stock units |
|
— | — | — |
|
— | — |
|
||||||||||||||||||||||||
| Shares withheld to satisfy tax withholdings | — | — |
(
|
(
|
— | — | — |
(
|
||||||||||||||||||||||||
| Stock-based compensation | — | — | — | — |
|
— |
|
|
||||||||||||||||||||||||
| Restricted stock grants |
|
|
— | — | — | — | — |
|
||||||||||||||||||||||||
| Restricted stock cancellations |
(
|
— | — | — | — | — | — | — | ||||||||||||||||||||||||
| Other comprehensive income | — | — | — | — | — |
|
— |
|
||||||||||||||||||||||||
| Balance at June 30, 2025 |
|
$ |
|
(
|
$ |
(
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
||||||||||||||||||
| Net income | — | — | — | — | — | — |
|
|
||||||||||||||||||||||||
| Purchase of treasury shares under stock repurchase program, inclusive of excise tax | — | — |
(
|
(
|
|
— | — |
(
|
||||||||||||||||||||||||
| Vesting of restricted stock units |
|
— | — | — |
|
— | — |
|
||||||||||||||||||||||||
| Shares withheld to satisfy tax withholdings | — | — |
(
|
(
|
— | — | — |
(
|
||||||||||||||||||||||||
| Stock-based compensation | — | — | — | — |
|
— |
|
|
||||||||||||||||||||||||
| Restricted stock grants |
|
|
— | — | — | — | — |
|
||||||||||||||||||||||||
| Restricted stock cancellations |
(
|
— | — | — | — | — | — | — | ||||||||||||||||||||||||
| Other comprehensive loss | — | — | — | — | — |
(
|
— |
(
|
||||||||||||||||||||||||
| Balance at September 30, 2025 |
|
$ |
|
(
|
$ |
(
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
||||||||||||||||||
|
6
|
|
Third Quarter 2025 Form 10-Q
|
||||||
| (dollars in thousands) | Common stock | Treasury stock |
Additional
paid-in capital |
Accumulated
other
comprehensive
loss
|
Retained earnings |
Total
stockholders' equity |
||||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | |||||||||||||||||||||||||||||
| Balance at December 31, 2023 |
|
$ |
|
(
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||
| Net income | — | — | — | — | — | — |
|
|
||||||||||||||||||||||||
| Purchase of treasury shares under stock repurchase program, inclusive of excise tax | — | — |
(
|
(
|
(
|
— | — |
(
|
||||||||||||||||||||||||
| Vesting of restricted stock units |
|
— | — | — |
|
— | — |
|
||||||||||||||||||||||||
| Shares withheld to satisfy tax withholdings | — | — |
(
|
(
|
— | — | — |
(
|
||||||||||||||||||||||||
| Stock-based compensation | — | — | — | — |
|
— |
|
|
||||||||||||||||||||||||
| Restricted stock grants |
|
|
— | — | — | — | — |
|
||||||||||||||||||||||||
| Restricted stock cancellations |
(
|
— | — | — | — | — | — | — | ||||||||||||||||||||||||
| Other comprehensive income | — | — | — | — | — |
|
— |
|
||||||||||||||||||||||||
| Balance at March 31, 2024 |
|
$ |
|
(
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Net income | — | — | — | — | — | — |
|
|
||||||||||||||||||||||||
| Vesting of restricted stock units |
|
— | — | — |
|
— | — |
|
||||||||||||||||||||||||
| Shares withheld to satisfy tax withholdings | — | — |
(
|
(
|
— | — | — |
(
|
||||||||||||||||||||||||
| Stock-based compensation | — | — | — | — |
|
— |
|
|
||||||||||||||||||||||||
| Restricted stock grants |
|
|
— | — | — | — | — |
|
||||||||||||||||||||||||
| Restricted stock cancellations |
(
|
— | — | — | — | — | — | — | ||||||||||||||||||||||||
| Other comprehensive loss | — | — | — | — | — |
(
|
— |
(
|
||||||||||||||||||||||||
| Balance at June 30, 2024 |
|
$ |
|
(
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Net income | — | — | — | — | — | — |
|
|
||||||||||||||||||||||||
| Purchase of treasury shares under stock repurchase program, inclusive of excise tax | — | — |
(
|
(
|
|
— | — |
(
|
||||||||||||||||||||||||
| Vesting of restricted stock units |
|
— | — | — |
|
— | — |
|
||||||||||||||||||||||||
| Shares withheld to satisfy tax withholdings | — | — |
(
|
(
|
— | — | — |
(
|
||||||||||||||||||||||||
| Stock-based compensation | — | — | — | — |
|
— |
|
|
||||||||||||||||||||||||
| Restricted stock grants |
|
|
— | — | — | — | — |
|
||||||||||||||||||||||||
| Restricted stock cancellations |
(
|
— | — | — | — | — | — | — | ||||||||||||||||||||||||
| Other comprehensive loss | — | — | — | — | — |
(
|
— |
(
|
||||||||||||||||||||||||
| Balance at September 30, 2024 |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
$ |
|
|||||||||||||||||
| The accompanying notes are an integral part of these condensed consolidated financial statements. | ||
|
Third Quarter 2025 Form 10-Q
|
|
7
|
||||||
| 1. Organization | ||
| 2. Basis of Presentation | ||
|
8
|
|
Third Quarter 2025 Form 10-Q
|
||||||
|
Third Quarter 2025 Form 10-Q
|
|
9
|
||||||
| 3. Earnings Per Share | ||
|
Three months ended
September 30,
|
Nine months ended
September 30,
|
||||||||||||||||
| (dollars in thousands, except per share amounts) |
2025
|
2024
|
2025
|
2024
|
|||||||||||||
| Numerator: | |||||||||||||||||
| Net income | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||
| Denominator: | |||||||||||||||||
| Weighted average common shares |
|
|
|
|
|||||||||||||
| Add effect of dilutive securities: | |||||||||||||||||
| Restricted stock and units |
|
|
|
|
|||||||||||||
| Weighted average common shares assuming dilution |
|
|
|
|
|||||||||||||
| Earnings per share | |||||||||||||||||
| Basic | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||
| Diluted | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||
| Anti-dilutive shares excluded from calculations of diluted earnings per share |
|
|
|
|
|||||||||||||
|
10
|
|
Third Quarter 2025 Form 10-Q
|
||||||
| 4. Fair Value Measurements | ||
| Fair value measurement using | ||||||||||||||||||||||||||
| (dollars in thousands) |
Quoted Prices in Active Markets for Identical Assets and Liabilities
(Level 1) |
Significant Other Observable Inputs
(Level 2) |
Significant Unobservable Inputs
(Level 3) |
Total | ||||||||||||||||||||||
| Fair value as of September 30, 2025 | ||||||||||||||||||||||||||
| Financial assets: | ||||||||||||||||||||||||||
| Interest rate swaps | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Foreign currency forward contracts |
|
|
|
|
||||||||||||||||||||||
| Total financial assets | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Fair value as of September 30, 2025 | ||||||||||||||||||||||||||
| Financial liabilities: | ||||||||||||||||||||||||||
| Interest rate swaps | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Foreign currency forward contracts |
|
|
|
|
||||||||||||||||||||||
| Total financial liabilities | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Fair value as of December 31, 2024 | ||||||||||||||||||||||||||
| Financial assets: | ||||||||||||||||||||||||||
| Interest rate swaps | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Foreign currency forward contracts |
|
|
|
|
||||||||||||||||||||||
| Total financial assets | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
|
Third Quarter 2025 Form 10-Q
|
|
11
|
||||||
| 5. Consolidated Financial Statement Details | ||
| (dollars in thousands) |
September 30,
2025 |
December 31,
2024 |
||||||
| Restricted cash due to customers | $ |
|
$ |
|
||||
|
Real estate escrow balances and other
|
|
|
||||||
| Total restricted cash | $ |
|
$ |
|
||||
|
12
|
|
Third Quarter 2025 Form 10-Q
|
||||||
| (dollars in thousands) |
September 30,
2025 |
December 31,
2024 |
||||||
|
Costs of obtaining contracts
(1)(2)
|
$ |
|
$ |
|
||||
|
Prepaid software maintenance and subscriptions
(3)
|
|
|
||||||
| Taxes, prepaid and receivable |
|
|
||||||
|
Implementation costs for cloud computing arrangements, net
(4)(5)
|
|
|
||||||
| Unbilled accounts receivable |
|
|
||||||
|
Investment in equity securities
(6)
|
|
|
||||||
| Prepaid insurance |
|
|
||||||
| Derivative instruments |
|
|
||||||
| Other assets |
|
|
||||||
| Total prepaid expenses and other assets |
|
|
||||||
| Less: Long-term portion |
|
|
||||||
| Prepaid expenses and other current assets | $ |
|
$ |
|
||||
| (dollars in thousands) |
September 30,
2025 |
December 31,
2024 |
||||||
|
Taxes payable
|
$ |
|
$ |
|
||||
| Customer credit balances |
|
|
||||||
| Unrecognized tax benefit |
|
|
||||||
| Derivative instruments |
|
|
||||||
| Accrued health care costs |
|
|
||||||
| Accrued vacation costs |
|
|
||||||
| Accrued commissions and salaries |
|
|
||||||
| Operating lease liabilities, current portion |
|
|
||||||
| Accrued transaction-based costs related to payments services |
|
|
||||||
|
Accrued legal costs
(1)
|
|
|
||||||
| Stock-based compensation liability |
|
|
||||||
|
Accrued costs to sell EVERFI
(2)
|
|
|
||||||
| Other liabilities |
|
|
||||||
| Total accrued expenses and other liabilities |
|
|
||||||
| Less: Long-term portion |
|
|
||||||
| Accrued expenses and other current liabilities | $ |
|
$ |
|
||||
|
Third Quarter 2025 Form 10-Q
|
|
13
|
||||||
|
Three months ended
September 30,
|
Nine months ended
September 30,
|
||||||||||||||||
| (dollars in thousands) |
2025
|
2024
|
2025
|
2024
|
|||||||||||||
| Interest income | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||
| Currency revaluation gains (losses) |
|
(
|
(
|
(
|
|||||||||||||
| Other income, net |
|
|
|
|
|||||||||||||
| Other income, net | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||
| 6. Debt | ||
| Debt balance at |
Weighted average
effective interest rate at |
||||||||||||||||
| (dollars in thousands) |
September 30,
2025 |
December 31,
2024 |
September 30,
2025 |
December 31,
2024 |
|||||||||||||
| Credit facility: | |||||||||||||||||
| Revolving credit loans | $ |
|
$ |
|
|
% |
|
% | |||||||||
| Term loans |
|
|
|
% |
|
% | |||||||||||
| Real estate loans |
|
|
|
% |
|
% | |||||||||||
| Other debt |
|
|
|
% |
|
% | |||||||||||
| Total debt |
|
|
|
% |
|
% | |||||||||||
| Less: Unamortized discount and debt issuance costs |
|
|
|||||||||||||||
| Less: Debt, current portion |
|
|
|
% |
|
% | |||||||||||
| Debt, net of current portion | $ |
|
$ |
|
|
% |
|
% | |||||||||
|
14
|
|
Third Quarter 2025 Form 10-Q
|
||||||
| (dollars in thousands) |
Term
in Months |
Number of
Annual Payments |
First Annual
Payment Due |
Original Loan
Value |
||||||||||
|
Effective dates of agreements
(1)
:
|
||||||||||||||
| December 2022 | 39 | 3 | January 2023 | $ |
|
|||||||||
| January 2023 | 36 | 3 | April 2023 | $ |
|
|||||||||
| April 2024 | 36 | 3 | May 2024 | $ |
|
|||||||||
| (dollars in thousands) | Total | ||||
| Balance at December 31, 2024 | $ |
|
|||
|
Additions
|
|
||||
|
Payments
|
(
|
||||
| Balance at September 30, 2025 | $ |
|
|||
| 7. Derivative Instruments | ||
|
Third Quarter 2025 Form 10-Q
|
|
15
|
||||||
| Asset derivatives | Liability derivatives | ||||||||||||||||||||||
| (dollars in thousands) | Balance sheet location |
September 30,
2025 |
December 31,
2024 |
Balance sheet location |
September 30,
2025 |
December 31,
2024 |
|||||||||||||||||
| Derivative instruments designated as hedging instruments: | |||||||||||||||||||||||
| Interest rate swaps, current portion |
Prepaid expenses
and other current assets |
$ |
|
$ |
|
Accrued expenses
and other current liabilities |
$ |
|
$ |
|
|||||||||||||
|
Foreign currency forward contracts, current portion
|
Prepaid expenses
and other current assets
|
$ |
|
$ |
|
Accrued expenses
and other current liabilities |
$ |
|
$ |
|
|||||||||||||
|
Interest rate swaps, long-term
|
Other assets |
|
|
Other liabilities |
|
|
|||||||||||||||||
| Total derivative instruments designated as hedging instruments | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
|
(Loss) gain recognized
in accumulated other
comprehensive
loss as of
|
Location
of (loss) gain
reclassified from
accumulated other
comprehensive
loss into
income
|
Gain reclassified from accumulated
other comprehensive loss into income
|
|||||||||||||||
| (dollars in thousands) |
September 30,
2025 |
Three months ended
September 30, 2025
|
Nine months ended
September 30, 2025
|
||||||||||||||
| Cash Flow Hedges | |||||||||||||||||
| Interest rate swaps | $ |
(
|
Interest expense | $ |
|
$ |
|
||||||||||
| Foreign currency forward contracts | $ |
(
|
Revenue | $ |
|
$ |
|
||||||||||
| Net Investment Hedges | |||||||||||||||||
| Foreign currency forward contracts | $ |
(
|
$ |
|
$ |
|
|||||||||||
|
September 30,
2024 |
Three months ended
September 30, 2024
|
Nine months ended
September 30, 2024
|
|||||||||||||||
| Cash Flow Hedges | |||||||||||||||||
| Interest rate swaps | $ |
(
|
Interest expense | $ |
|
$ |
|
||||||||||
| Foreign currency forward contracts | $ |
|
Revenue | $ |
|
$ |
|
||||||||||
| Net Investment Hedges | |||||||||||||||||
| Foreign currency forward contracts | $ |
(
|
$ |
|
$ |
|
|||||||||||
|
16
|
|
Third Quarter 2025 Form 10-Q
|
||||||
| 8. Commitments and Contingencies | ||
|
Three months ended
September 30,
|
Nine months ended
September 30,
|
||||||||||||||||
| (dollars in thousands) |
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Operating lease cost
(1)
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||
| Variable lease cost |
|
|
|
|
|||||||||||||
| Sublease income |
(
|
(
|
(
|
(
|
|||||||||||||
| Net lease cost | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||
|
Third Quarter 2025 Form 10-Q
|
|
17
|
||||||
|
Years ending December 31,
(dollars in thousands) |
Operating leases | ||||||||||
| 2025 - remaining | $ |
|
|||||||||
| 2026 |
|
||||||||||
| 2027 |
|
||||||||||
| 2028 |
|
||||||||||
| 2029 |
|
||||||||||
| Thereafter |
|
||||||||||
| Total lease payments |
|
||||||||||
| Less: Amount representing interest |
(
|
||||||||||
| Present value of future payments | $ |
|
|||||||||
|
18
|
|
Third Quarter 2025 Form 10-Q
|
||||||
| 9. Income Taxes | ||
|
Three months ended
September 30,
|
Nine months ended
September 30,
|
||||||||||||||||
| (dollars in thousands) |
2025
|
2024
|
2025
|
2024
|
|||||||||||||
| Income tax (benefit) provision | $ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||
| Effective income tax rate |
(
|
% |
|
% |
|
% |
|
% | |||||||||
|
Third Quarter 2025 Form 10-Q
|
|
19
|
||||||
| 10. Stockholders' Equity | ||
|
Three months ended
September 30,
|
Nine months ended
September 30,
|
||||||||||||||||
| (in thousands) |
2025
|
2024
|
2025
|
2024
|
|||||||||||||
| Accumulated other comprehensive (loss) income, beginning of period | $ |
(
|
$ |
|
$ |
(
|
$ |
(
|
|||||||||
| By component: | |||||||||||||||||
| Gains and losses on cash flow hedges: | |||||||||||||||||
| Accumulated other comprehensive (loss) income balance, beginning of period | $ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||
|
Other comprehensive income (loss) before reclassifications, net of tax effects of $
|
|
(
|
(
|
|
|||||||||||||
| Amounts reclassified from accumulated other comprehensive income (loss) |
(
|
(
|
(
|
(
|
|||||||||||||
| Tax expense (benefit) included in provision for income taxes |
|
|
(
|
|
|||||||||||||
| Total amounts reclassified from accumulated other comprehensive income (loss) |
(
|
(
|
(
|
(
|
|||||||||||||
| Net current-period other comprehensive loss |
(
|
(
|
(
|
(
|
|||||||||||||
| Accumulated other comprehensive loss balance, end of period | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||
| Foreign currency translation adjustment: | |||||||||||||||||
| Accumulated other comprehensive loss balance, beginning of period | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||
| Translation adjustment |
(
|
|
|
|
|||||||||||||
| Accumulated other comprehensive loss balance, end of period |
(
|
(
|
(
|
(
|
|||||||||||||
| Accumulated other comprehensive loss, end of period | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||
|
20
|
|
Third Quarter 2025 Form 10-Q
|
||||||
| 11. Segment Information | ||
| 12. Revenue Recognition | ||
| (in thousands) |
September 30,
2025 |
December 31,
2024 |
||||||
| Total deferred revenue | $ |
|
$ |
|
||||
|
Three months ended
September 30,
|
Nine months ended
September 30,
|
||||||||||||||||
| (dollars in thousands) |
2025
|
2024
(1)
|
2025
|
2024
(1)
|
|||||||||||||
| United States | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||
| United Kingdom |
|
|
|
|
|||||||||||||
| Other countries |
|
|
|
|
|||||||||||||
| Total revenue | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||
|
Third Quarter 2025 Form 10-Q
|
|
21
|
||||||
|
Three months ended
September 30,
|
Nine months ended
September 30,
|
||||||||||||||||
| (dollars in thousands) |
2025
|
2024
(1)
|
2025
|
2024
(1)
|
|||||||||||||
| Contractual recurring | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||
| Transactional recurring |
|
|
|
|
|||||||||||||
| Total recurring revenue | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||
| One-time services and other |
|
|
|
|
|||||||||||||
| Total revenue | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||
|
22
|
|
Third Quarter 2025 Form 10-Q
|
||||||
| 13. Revision of Prior Period Financial Statements | ||
| (dollars in millions) | As of December 31, 2023 | ||||||||||
|
As
reported |
Adjustment |
As
revised |
|||||||||
| Prepaid expenses and other current assets | $ |
|
$ |
|
$ |
|
|||||
| Total current assets |
|
|
|
||||||||
| Total assets |
|
|
|
||||||||
| Accrued expenses and other current liabilities |
|
|
|
||||||||
| Deferred revenue, current portion |
|
(
|
|
||||||||
| Total current liabilities |
|
(
|
|
||||||||
| Total liabilities |
|
(
|
|
||||||||
| Retained earnings |
|
|
|
||||||||
| Total stockholders' equity |
|
|
|
||||||||
| Total liabilities and stockholders’ equity |
|
|
|
||||||||
|
Third Quarter 2025 Form 10-Q
|
|
23
|
||||||
| (dollars in millions) | As of March 31, 2024 | As of June 30, 2024 | As of September 30, 2024 | As of December 31, 2024 | ||||||||||||||||||||||||||||||||||
|
As
reported |
Adjustment |
As
revised |
As
reported |
Adjustment |
As
revised |
As
reported |
Adjustment |
As
revised |
As
reported |
Adjustment |
As
revised |
|||||||||||||||||||||||||||
| Prepaid expenses and other current assets | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||
| Total current assets |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||
| Total assets |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||
| Accrued expenses and other current liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||
| Deferred revenue, current portion |
|
(
|
|
|
(
|
|
|
(
|
|
|
(
|
|
||||||||||||||||||||||||||
| Total current liabilities |
|
(
|
|
|
(
|
|
|
(
|
|
|
|
|
||||||||||||||||||||||||||
| Deferred tax liability |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||
| Total noncurrent liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||
| Total liabilities |
|
|
|
|
|
|
|
(
|
|
|
|
|
||||||||||||||||||||||||||
| Additional paid-in capital |
|
(
|
|
|
(
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||
| Retained earnings (accumulated deficit) |
|
|
|
|
|
|
|
|
|
(
|
(
|
(
|
||||||||||||||||||||||||||
| Total stockholders' equity |
|
|
|
|
|
|
|
|
|
|
(
|
|
||||||||||||||||||||||||||
| Total liabilities and stockholders’ equity |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||
| (dollars in millions) | As of March 31, 2025 | As of June 30, 2025 | ||||||||||||||||||
|
As
reported |
Adjustment |
As
revised |
As
reported |
Adjustment |
As
revised |
|||||||||||||||
| Accounts receivable, net of allowance | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||
| Prepaid expenses and other current assets |
|
|
|
|
|
|
||||||||||||||
| Total current assets |
|
|
|
|
|
|
||||||||||||||
| Total assets |
|
|
|
|
|
|
||||||||||||||
| Accrued expenses and other current liabilities |
|
|
|
|
|
|
||||||||||||||
| Deferred revenue, current portion |
|
(
|
|
|
(
|
|
||||||||||||||
| Total current liabilities |
|
|
|
|
|
|
||||||||||||||
| Deferred tax liability |
|
|
|
|
|
|
||||||||||||||
| Total noncurrent liabilities |
|
|
|
|
|
|
||||||||||||||
| Total liabilities |
|
|
|
|
|
|
||||||||||||||
| Accumulated deficit |
(
|
(
|
(
|
(
|
(
|
(
|
||||||||||||||
| Total stockholders' equity |
|
(
|
|
|
(
|
|
||||||||||||||
| Total liabilities and stockholders’ equity |
|
|
|
|
|
|
||||||||||||||
|
24
|
|
Third Quarter 2025 Form 10-Q
|
||||||
| (dollars in millions, except per share amounts) |
Twelve months ended
December 31, 2023 |
||||||||||
|
As
reported |
Adjustment |
As
revised |
|||||||||
| Revenue | $ |
|
$ |
|
$ |
|
|||||
| Cost of revenue |
|
|
|
||||||||
| Gross profit |
|
(
|
|
||||||||
| Research and development |
|
(
|
|
||||||||
| Total operating expenses |
|
(
|
|
||||||||
| Income from operations |
|
|
|
||||||||
| Income before provision for income taxes |
|
|
|
||||||||
| Income tax provision |
|
|
|
||||||||
| Net income |
|
|
|
||||||||
| Earnings per share | |||||||||||
| Basic |
|
|
|
||||||||
| Diluted |
|
|
|
||||||||
| Comprehensive (loss) |
(
|
|
(
|
||||||||
| (dollars in millions, except per share amounts) |
Three months ended
March 31, 2024 |
Three months ended
June 30, 2024 |
Three months ended
September 30, 2024 |
|||||||||||||||||||||||||||||||||||
|
As
reported |
Adjustment |
As
revised |
As
reported |
Adjustment |
As
revised |
As
reported |
Adjustment |
As
revised |
||||||||||||||||||||||||||||||
| Revenue | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||||
| Cost of revenue |
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
| Gross profit |
|
(
|
|
|
(
|
|
|
(
|
|
|||||||||||||||||||||||||||||
| Sales, marketing and customer success |
|
(
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
| Research and development |
|
(
|
|
|
(
|
|
|
(
|
|
|||||||||||||||||||||||||||||
| General and administrative |
|
(
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
| Total operating expenses |
|
(
|
|
|
(
|
|
|
|
|
|||||||||||||||||||||||||||||
| Income (loss) from operations |
|
|
|
|
(
|
|
|
(
|
|
|||||||||||||||||||||||||||||
| Income (loss) before (benefit) provision for income taxes |
|
|
|
|
(
|
|
|
(
|
|
|||||||||||||||||||||||||||||
| Income tax (benefit) provision |
(
|
|
(
|
|
(
|
|
|
(
|
|
|||||||||||||||||||||||||||||
| Net income (loss) |
|
|
|
|
(
|
|
|
(
|
|
|||||||||||||||||||||||||||||
| Earnings (loss) per share | ||||||||||||||||||||||||||||||||||||||
| Basic |
|
|
|
|
(
|
|
|
(
|
|
|||||||||||||||||||||||||||||
| Diluted |
|
|
|
|
(
|
|
|
(
|
|
|||||||||||||||||||||||||||||
| Comprehensive income (loss) |
|
|
|
|
(
|
|
|
(
|
|
|||||||||||||||||||||||||||||
|
Third Quarter 2025 Form 10-Q
|
|
25
|
||||||
| (dollars in millions, except per share amounts) |
Six months ended
June 30, 2024 |
Nine months ended
September 30, 2024 |
Twelve months ended
December 31, 2024 |
||||||||||||||||||||||||||
|
As
reported |
Adjustment |
As
revised |
As
reported |
Adjustment |
As
revised |
As
reported |
Adjustment |
As
revised |
|||||||||||||||||||||
| Revenue | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||
| Cost of revenue |
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
| Gross profit |
|
(
|
|
|
(
|
|
|
(
|
|
||||||||||||||||||||
| Sales, marketing and customer success |
|
(
|
|
|
|
|
|
|
|
||||||||||||||||||||
| Research and development |
|
(
|
|
|
(
|
|
|
(
|
|
||||||||||||||||||||
| General and administrative |
|
(
|
|
|
|
|
|
|
|
||||||||||||||||||||
| Total operating expenses |
|
(
|
|
|
(
|
|
|
(
|
|
||||||||||||||||||||
| Income (loss) from operations |
|
|
|
|
(
|
|
(
|
(
|
(
|
||||||||||||||||||||
| Income (loss) before provision (benefit) for income taxes |
|
|
|
|
(
|
|
(
|
(
|
(
|
||||||||||||||||||||
| Income tax provision (benefit) |
|
|
|
|
|
|
(
|
|
(
|
||||||||||||||||||||
| Net income (loss) |
|
|
|
|
(
|
|
(
|
(
|
(
|
||||||||||||||||||||
| Earnings (loss) per share | |||||||||||||||||||||||||||||
| Basic |
|
|
|
|
(
|
|
(
|
(
|
(
|
||||||||||||||||||||
| Diluted |
|
|
|
|
(
|
|
(
|
(
|
(
|
||||||||||||||||||||
| Comprehensive income (loss) |
|
|
|
|
(
|
|
(
|
(
|
(
|
||||||||||||||||||||
| (dollars in millions, except per share amounts) |
Three months ended
March 31, 2025 |
Three months ended
June 30, 2025 |
Six months ended
June 30, 2025 |
||||||||||||||||||||||||||
|
As
reported |
Adjustment |
As
revised |
As
reported |
Adjustment |
As
revised |
As
reported |
Adjustment |
As
revised |
|||||||||||||||||||||
| Revenue | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||
| Gross profit |
|
(
|
|
|
|
|
|
(
|
|
||||||||||||||||||||
| Income from operations |
|
(
|
|
|
|
|
|
(
|
|
||||||||||||||||||||
| Income before provision for income taxes |
|
(
|
|
|
|
|
|
(
|
|
||||||||||||||||||||
| Income tax provision |
|
(
|
|
|
|
|
|
|
|
||||||||||||||||||||
| Net income |
|
(
|
|
|
|
|
|
(
|
|
||||||||||||||||||||
| Earnings per share | |||||||||||||||||||||||||||||
| Basic |
|
(
|
|
|
|
|
|
|
|
||||||||||||||||||||
| Diluted |
|
(
|
|
|
|
|
|
|
|
||||||||||||||||||||
| Comprehensive income |
|
(
|
|
|
|
|
|
(
|
|
||||||||||||||||||||
|
26
|
|
Third Quarter 2025 Form 10-Q
|
||||||
| (dollars in millions) |
Twelve months ended
December 31, 2023 |
||||||||||
|
As
reported |
Adjustment |
As
revised |
|||||||||
| Cash flows from operating activities | |||||||||||
| Net income | $ |
|
$ |
|
$ |
|
|||||
| Changes in operating assets and liabilities, net of acquisition and disposal of businesses: | |||||||||||
| Prepaid expenses and other assets |
|
(
|
|
||||||||
| Accrued expenses and other liabilities |
(
|
|
(
|
||||||||
| Deferred revenue |
|
(
|
|
||||||||
| Net cash provided by operating activities |
|
|
|
||||||||
| (dollars in millions) |
Three months ended
March 31, 2024 |
Six months ended
June 30, 2024 |
Nine months ended
September 30, 2024 |
Twelve months ended
December 31, 2024 |
||||||||||||||||||||||||||||||||||
|
As
reported |
Adjustment |
As
revised |
As
reported |
Adjustment |
As
revised |
As
reported |
Adjustment |
As
revised |
As
reported |
Adjustment |
As
revised |
|||||||||||||||||||||||||||
| Cash flows from operating activities | ||||||||||||||||||||||||||||||||||||||
| Net income (loss) | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||||||||||||||||||||||||||||||||||||||
| Stock-based compensation expense |
|
(
|
|
|
(
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||
| Deferred taxes |
(
|
|
(
|
(
|
|
(
|
(
|
|
(
|
(
|
|
(
|
||||||||||||||||||||||||||
| Changes in operating assets and liabilities, net of acquisition and disposal of businesses: | ||||||||||||||||||||||||||||||||||||||
| Prepaid expenses and other assets |
(
|
|
(
|
(
|
|
(
|
(
|
(
|
(
|
|
(
|
|
||||||||||||||||||||||||||
| Trade accounts payable |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||
| Accrued expenses and other liabilities |
|
|
|
(
|
|
(
|
(
|
|
(
|
(
|
|
(
|
||||||||||||||||||||||||||
| Deferred revenue |
(
|
|
(
|
|
|
|
|
|
|
(
|
|
(
|
||||||||||||||||||||||||||
| Net cash provided by operating activities |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||
| Cash flows from investing activities | ||||||||||||||||||||||||||||||||||||||
| Purchase of property and equipment |
(
|
(
|
(
|
(
|
|
(
|
(
|
|
(
|
(
|
|
(
|
||||||||||||||||||||||||||
| Net cash used in investing activities |
(
|
(
|
(
|
(
|
|
(
|
(
|
|
(
|
(
|
|
(
|
||||||||||||||||||||||||||
|
Third Quarter 2025 Form 10-Q
|
|
27
|
||||||
| (dollars in millions) |
Three months ended
March 31, 2025 |
Six months ended
June 30, 2025 |
||||||||||||||||||
|
As
reported |
Adjustment |
As
revised |
As
reported |
Adjustment |
As
revised |
|||||||||||||||
| Cash flows from operating activities | ||||||||||||||||||||
| Net income | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||||||||||
| Provision for credit losses and sales returns |
|
|
|
|
(
|
|
||||||||||||||
| Changes in operating assets and liabilities, net of acquisition and disposal of businesses: | ||||||||||||||||||||
| Prepaid expenses and other assets |
(
|
|
(
|
(
|
|
(
|
||||||||||||||
| Accrued expenses and other liabilities |
(
|
|
(
|
(
|
|
(
|
||||||||||||||
| Deferred revenue |
(
|
|
(
|
|
|
|
||||||||||||||
| Net cash provided by operating activities |
|
|
|
|
|
|
||||||||||||||
|
Retained earnings (accumulated deficit) |
Total stockholders' equity | |||||||||||||||||||
| (dollars in millions) |
As
reported |
Adjustment |
As
revised |
As
reported |
Adjustment |
As
revised |
||||||||||||||
| Balance at December 31, 2022 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||
| Net income |
|
|
|
|
|
|
||||||||||||||
| Balance at December 31, 2023 |
|
|
|
|
|
|
||||||||||||||
| Net (loss) |
(
|
(
|
(
|
(
|
(
|
(
|
||||||||||||||
| Balance at December 31, 2024 |
(
|
(
|
(
|
|
(
|
|
||||||||||||||
|
28
|
|
Third Quarter 2025 Form 10-Q
|
||||||
| Additional paid-in capital |
Retained earnings
(accumulated deficit) |
Total stockholders' equity | |||||||||||||||||||||||||||
| (dollars in millions) |
As
reported |
Adjustment |
As
revised |
As
reported |
Adjustment |
As
revised |
As
reported |
Adjustment |
As
revised |
||||||||||||||||||||
| Balance at December 31, 2023 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||
| Net income | — | — | — |
|
|
|
|
|
|
||||||||||||||||||||
| Stock-based compensation |
|
(
|
|
|
|
|
|
(
|
|
||||||||||||||||||||
| Balance at March 31, 2024 |
|
(
|
|
|
|
|
|
|
|
||||||||||||||||||||
| Net income | — | — | — |
|
(
|
|
|
(
|
|
||||||||||||||||||||
| Stock-based compensation |
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
| Balance at June 30, 2024 |
|
(
|
|
|
|
|
|
|
|
||||||||||||||||||||
| Net income | — | — | — |
|
(
|
|
|
(
|
|
||||||||||||||||||||
| Stock-based compensation |
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
| Balance at September 30, 2024 |
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
| Balance at December 31, 2024 |
|
|
|
(
|
(
|
(
|
|
(
|
|
||||||||||||||||||||
| Net income | — | — | — |
|
(
|
|
|
(
|
|
||||||||||||||||||||
| Balance at March 31, 2025 |
|
|
|
(
|
(
|
(
|
|
(
|
|
||||||||||||||||||||
| Net income | — | — | — |
|
|
|
|
|
|
||||||||||||||||||||
| Balance at June 30, 2025 |
|
|
|
(
|
(
|
(
|
|
(
|
|
||||||||||||||||||||
|
Third Quarter 2025 Form 10-Q
|
|
29
|
||||||
| Executive Summary | ||
|
30
|
|
Third Quarter 2025 Form 10-Q
|
||||||
| Total revenue ($M) |
Income from operations ($M)
|
|||||||
| YoY Growth (%) | YoY Growth (%) | |||||||
|
Third Quarter 2025 Form 10-Q
|
|
31
|
||||||
| - |
Decreases in contractual recurring revenue of $11.7 million and $40.1 million, respectively, primarily related to our sale of EVERFI which represented $18.4 million and $63.9 million, respectively. These decreases were partially offset by the positive impact of our pricing initiatives and the performance of our cloud solutions.
|
||||||||||
| - |
Decreases in one-time consulting revenue of $1.4 million and $2.6 million, respectively, primarily due to our sale of EVERFI Limited in March 2024 and, to a lesser extent, fewer sales of implementation and customization services.
|
||||||||||
| + |
Increases in transactional recurring revenue of $7.7 million and $23.4 million, respectively, primarily due to increases in volume for our Blackbaud Integrated Payments and, to a lesser extent, positive results related to pricing initiatives; also contributing to the increases in transactional recurring revenue during the three and nine months ended September 30, 2025 were increases related to fluctuations in foreign currency exchange rates of $0.7 million and $2.2 million, respectively.
|
||||||||||
| + |
Decreases in compensation costs other than stock-based compensation of $10.3 million and $33.0 million, respectively, primarily due to our sale of EVERFI
|
||||||||||
| + |
Decreases in amortization of intangible assets from business combinations of $8.2 million and $24.1 million, respectively, largely due to the previously disclosed impairment charge related to our EVERFI asset group in December 2024, which primarily included finite-lived intangible assets
|
||||||||||
| + |
Decrease in Security Incident-related expenses of $10.0 million, for the nine months ended September 30, 2025, largely related to decreases in loss contingency accruals. See Note 8 to our unaudited, condensed consolidated financial statements in this report for our discussion of the Security Incident.
|
||||||||||
| + |
Decreases in third-party contractor costs of $1.6 million and $8.7 million, respectively, primarily due to our sale of EVERFI
|
||||||||||
| + |
Decreases in advertising costs of $1.4 million and $4.3 million, respectively, primarily due to our sale of EVERFI
|
||||||||||
| + |
Decrease in stock-based compensation expense of $5.4 million, for the nine months ended September 30, 2025, primarily due to a decrease in the grant date fair value of equity award grants, and to a lesser extent, our sale of EVERFI; partially offset by an increase primarily due to estimated overall Company performance against 2025 goals
|
||||||||||
| + |
Decrease in rent expense of $2.9 million, for the nine months ended September 30, 2025, primarily related to our release from our lease for office space in Washington, DC in February 2025
|
||||||||||
| - |
Increase in acquisition and disposition-related costs within general and administrative expenses of $20.9 million, for the nine months ended September 30, 2025, primarily related to our release from our lease for office space in Washington, DC in February 2025
|
||||||||||
| - |
Decreases in total revenue, as described above
|
||||||||||
| - |
Decreases of $3.1 million and $5.3 million, respectively, in software development costs that were required to be capitalized under GAAP, primarily due to our sale of EVERFI
|
||||||||||
| - |
Increases in transaction-based costs of $1.5 million and $4.9 million, respectively, related to the increase in the volume of transactions for which we process payments and, to a lesser extent, increases in vendor rates
|
||||||||||
| - |
Increase in third-party software costs of $2.5 million, for the nine months ended September 30, 2025, primarily related to investments in our internal cybersecurity program
|
||||||||||
| - |
Increase in employee severance of $1.9 million, for the nine months ended September 30, 2025, related to a modest and targeted headcount reduction during the three months ended June 30, 2025
|
||||||||||
|
32
|
|
Third Quarter 2025 Form 10-Q
|
||||||
| Gross dollar retention | ||||||||
| Results of Operations | ||
|
Third Quarter 2025 Form 10-Q
|
|
33
|
||||||
| Revenue ($M) | Cost of revenue ($M) |
Gross profit ($M)
and gross margin (%) |
||||||||||||
| YoY Growth (%) | YoY Growth (%) | |||||||||||||
|
34
|
|
Third Quarter 2025 Form 10-Q
|
||||||
| - |
Decreases in amortization of intangible assets from business combinations of $7.9 million and $23.1 million, respectively, largely due to the previously disclosed impairment charge related to our EVERFI asset group in December 2024, which primarily included finite-lived intangible assets
|
||||||||||
| - |
Decreases in compensation costs of $5.3 million and $15.9 million, respectively, primarily due to our sale of EVERFI
|
||||||||||
| - |
Decreases in allocated overhead costs of $1.7 million and $4.3 million, respectively, primarily related to a reduction in facilities costs and the decreased headcount from our sale of EVERFI
|
||||||||||
| - |
Decreases in third-party contractor costs of $1.2 million and $2.6 million, respectively, largely related to our sale of EVERFI and, to a lesser extent, decreased use of outside contractors
|
||||||||||
| + |
Increases in transaction-based costs of $1.5 million and $4.7 million, respectively, related to the increase in the volume of transactions for which we process payments and, to a lesser extent, increases in vendor rates
|
||||||||||
|
Sales, marketing and
customer success ($M) |
Research and
development ($M) |
General and
administrative ($M) |
||||||||||||
| Percentages indicate expenses as a percentage of total revenue | ||||||||||||||
|
Third Quarter 2025 Form 10-Q
|
|
35
|
||||||
| - |
Decreases in compensation costs of $2.3 million and $7.7 million, respectively, primarily related to our sale of EVERFI
|
||||||||||
| - |
Decreases in advertising costs of $1.4 million and $4.3 million, respectively, primarily due to our sale of EVERFI
|
||||||||||
| - |
Decreases in compensation costs of $2.7 million and $10.6 million, respectively, primarily related to our sale of EVERFI
|
||||||||||
| - |
Decrease in third-party contractor costs of $5.4 million, for the nine months ended September 30, 2025, primarily related to our sale of EVERFI
|
||||||||||
| + |
Decreases in software development costs of $3.9 million and $5.6 million, respectively, that were required to be capitalized under GAAP, primarily due to our sale of EVERFI
|
||||||||||
|
36
|
|
Third Quarter 2025 Form 10-Q
|
||||||
| + |
Decrease in total costs allocated from general and administrative expense of $3.4 million primarily related to a reduction in facilities costs and the decreased headcount from our sale of EVERFI. Depreciation, facilities and IT support (including cybersecurity) costs are pooled and recorded to general and administrative expense and allocated to other lines of our statements of comprehensive income based on headcount.
|
||||||||||
| + |
Increase in acquisition and disposition-related costs of $20.9 million primarily related to our release from our lease for office space in Washington, DC in February 2025
|
||||||||||
| + |
Decrease in total costs allocated from general and administrative expense of $6.8 million primarily related to a reduction in facilities costs and the decreased headcount from our sale of EVERFI. Depreciation, facilities and IT support (including cybersecurity) costs are pooled and recorded to general and administrative expense and allocated to other lines of our statements of comprehensive income based on headcount.
|
||||||||||
| + |
Increase in third-party software costs of $2.2 million primarily related to investments in our internal cybersecurity program
|
||||||||||
| - |
Decrease in Security Incident-related expenses of $10.0 million largely related to decreases in loss contingency accruals. See Note 8 to our unaudited, condensed consolidated financial statements in this report for our discussion of the Security Incident.
|
||||||||||
| - |
Decrease in rent expense of $2.6 million primarily related to our release from our lease for office space in Washington, DC in February 2025
|
||||||||||
| - |
Decrease in stock-based compensation costs of $2.3 million primarily due to a decrease in the grant date fair value of equity award grants, and to a lesser extent, our sale of EVERFI; partially offset by an increase primarily due to estimated overall Company performance against 2025 goals
|
||||||||||
| - |
Decrease in compensation costs other than stock-based compensation of $1.7 million primarily due to our sale of EVERFI
|
||||||||||
| Interest expense ($M) | ||||||||
| Percentages indicate expenses as a percentage of total revenue | ||||||||
|
Third Quarter 2025 Form 10-Q
|
|
37
|
||||||
|
Other income, net ($M)
|
||||||||
| Percentages indicate other income, net as a percentage of total revenue | ||||||||
| (dollars in millions) |
September 30,
2025 |
December 31,
2024 |
Change | ||||||||
|
Deferred revenue
(1)
|
$ | 384.9 | $ | 360.6 | 6.8 | % | |||||
| Less: Long-term portion | 1.8 | 2.0 | (12.0) | % | |||||||
|
Current portion
(1)
|
$ | 383.1 | $ | 358.5 | 6.9 | % | |||||
|
38
|
|
Third Quarter 2025 Form 10-Q
|
||||||
|
Income tax (benefit) provision ($M)
|
||||||||
| Percentages indicate effective income tax rates | ||||||||
|
Third Quarter 2025 Form 10-Q
|
|
39
|
||||||
|
40
|
|
Third Quarter 2025 Form 10-Q
|
||||||
|
Three months ended
September 30,
|
Nine months ended
September 30,
|
||||||||||||||||
| (dollars in millions, except per share amounts) |
2025
|
2024
|
2025
|
2024
|
|||||||||||||
| GAAP Revenue | $ | 281.1 | $ | 286.6 | $ | 833.1 | $ | 852.5 | |||||||||
| GAAP gross profit | $ | 167.5 | $ | 157.3 | $ | 491.0 | $ | 468.9 | |||||||||
| GAAP gross margin | 59.6 | % | 54.9 | % | 58.9 | % | 55.0 | % | |||||||||
| Non-GAAP adjustments: | |||||||||||||||||
|
Add: Stock-based compensation expense
|
2.9 | 2.9 | 8.8 | 10.1 | |||||||||||||
|
Add: Amortization of intangibles from business combinations
|
6.8 | 14.7 | 20.9 | 44.0 | |||||||||||||
|
Add: Employee severance
|
— | — | 0.3 | — | |||||||||||||
|
Subtotal
(1)
|
9.6 | 17.6 | 30.0 | 54.0 | |||||||||||||
|
Non-GAAP gross profit
(1)
|
$ | 177.1 | $ | 174.9 | $ | 521.0 | $ | 522.9 | |||||||||
| Non-GAAP gross margin | 63.0 | % | 61.0 | % | 62.5 | % | 61.3 | % | |||||||||
| GAAP income from operations | $ | 54.6 | $ | 41.1 | $ | 131.6 | $ | 95.9 | |||||||||
| GAAP operating margin | 19.4 | % | 14.4 | % | 15.8 | % | 11.2 | % | |||||||||
| Non-GAAP adjustments: | |||||||||||||||||
|
Add: Stock-based compensation expense
|
21.7 | 21.1 | 71.1 | 76.4 | |||||||||||||
|
Add: Amortization of intangibles from business combinations
|
7.4 | 15.6 | 22.6 | 46.7 | |||||||||||||
|
Add: Employee severance
|
(0.2) | — | 1.9 | — | |||||||||||||
|
Add: Acquisition and disposition-related costs
(2)
|
0.4 | 0.2 | 25.8 | 4.9 | |||||||||||||
|
Add: Security Incident-related costs
(3)
|
0.2 | 0.6 | 2.8 | 12.8 | |||||||||||||
|
Subtotal
(1)
|
29.4 | 37.6 | 124.1 | 140.8 | |||||||||||||
|
Non-GAAP income from operations
(1)
|
$ | 84.0 | $ | 78.7 | $ | 255.8 | $ | 236.7 | |||||||||
| Non-GAAP operating margin | 29.9 | % | 27.5 | % | 30.7 | % | 27.8 | % | |||||||||
| GAAP income before (benefit) provision for income taxes | $ | 41.0 | $ | 30.0 | $ | 86.0 | $ | 65.4 | |||||||||
| GAAP net income | $ | 47.5 | $ | 18.3 | $ | 78.3 | $ | 46.8 | |||||||||
| Shares used in computing GAAP diluted earnings per share | 48,498,285 | 51,632,569 | 48,634,027 | 52,107,147 | |||||||||||||
| GAAP diluted earnings per share | $ | 0.98 | $ | 0.35 | $ | 1.61 | $ | 0.90 | |||||||||
| Non-GAAP adjustments: | |||||||||||||||||
| Add: GAAP income tax (benefit) provision | (6.4) | 11.7 | 7.7 | 18.6 | |||||||||||||
| Add: Total non-GAAP adjustments affecting income from operations | 29.4 | 37.6 | 124.1 | 140.8 | |||||||||||||
|
Non-GAAP income before provision for income taxes
(1)
|
70.5 | 67.6 | 210.1 | 206.2 | |||||||||||||
|
Assumed non-GAAP income tax provision
(4)
|
17.3 | 16.6 | 51.5 | 50.5 | |||||||||||||
|
Non-GAAP net income
(1)
|
$ | 53.2 | $ | 51.0 | $ | 158.6 | $ | 155.7 | |||||||||
| Shares used in computing non-GAAP diluted earnings per share | 48,498,285 | 51,632,569 | 48,634,027 | 52,107,147 | |||||||||||||
| Non-GAAP diluted earnings per share | $ | 1.10 | $ | 0.99 | $ | 3.26 | $ | 2.99 | |||||||||
|
Third Quarter 2025 Form 10-Q
|
|
41
|
||||||
| (dollars in millions) |
Three months ended
September 30,
|
Nine months ended
September 30,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
||||||||||||||
|
GAAP revenue
|
$ | 281.1 | $ | 286.6 | $ | 833.1 | $ | 852.5 | |||||||||
| GAAP revenue growth | (1.9) | % | (2.3) | % | |||||||||||||
|
Less: Non-GAAP revenue from divested businesses
(1)
|
— | (19.3) | — | (66.5) | |||||||||||||
|
Non-GAAP organic revenue
(2)
|
$ | 281.1 | $ | 267.3 | $ | 833.1 | $ | 786.0 | |||||||||
| Non-GAAP organic revenue growth | 5.2 | % | 6.0 | % | |||||||||||||
|
Non-GAAP organic revenue
(2)
|
$ | 281.1 | $ | 267.3 | $ | 833.1 | $ | 786.0 | |||||||||
|
Foreign currency impact on Non-GAAP organic revenue
(3)
|
(1.0) | — | (2.6) | — | |||||||||||||
|
Non-GAAP organic revenue on constant currency basis
(3)
|
$ | 280.2 | $ | 267.3 | $ | 830.5 | $ | 786.0 | |||||||||
| Non-GAAP organic revenue growth on constant currency basis | 4.8 | % | 5.7 | % | |||||||||||||
| GAAP recurring revenue | $ | 275.8 | $ | 279.9 | $ | 815.4 | $ | 832.2 | |||||||||
| GAAP recurring revenue growth | (1.5) | % | (2.0) | % | |||||||||||||
|
Less: Non-GAAP recurring revenue from divested businesses
(1)
|
— | (18.4) | — | (63.9) | |||||||||||||
|
Non-GAAP organic recurring revenue
(2)
|
$ | 275.8 | $ | 261.5 | $ | 815.4 | $ | 768.3 | |||||||||
| Non-GAAP organic recurring revenue growth | 5.5 | % | 6.1 | % | |||||||||||||
|
Non-GAAP organic recurring revenue
(2)
|
$ | 275.8 | $ | 261.5 | $ | 815.4 | $ | 768.3 | |||||||||
|
Foreign currency impact on non-GAAP organic recurring revenue
(3)
|
(1.0) | — | (2.6) | — | |||||||||||||
|
Non-GAAP organic recurring revenue on constant currency basis
(3)
|
$ | 274.8 | $ | 261.5 | $ | 812.8 | $ | 768.3 | |||||||||
| Non-GAAP organic recurring revenue growth on constant currency basis | 5.1 | % | 5.8 | % | |||||||||||||
|
42
|
|
Third Quarter 2025 Form 10-Q
|
||||||
|
Three months ended
September 30,
|
Nine months ended
September 30,
|
||||||||||||||||
| (dollars in millions) |
2025
|
2024
|
2025
|
2024
|
|||||||||||||
| GAAP net income | $ | 47.5 | $ | 18.3 | $ | 78.3 | $ | 46.8 | |||||||||
| Non-GAAP adjustments: | |||||||||||||||||
| Add: Interest, net | 14.4 | 11.0 | 46.1 | 32.2 | |||||||||||||
|
Add: GAAP income tax (benefit) provision
|
(6.4) | 11.7 | 7.7 | 18.6 | |||||||||||||
|
Add: Depreciation
|
2.2 | 3.3 | 7.8 | 9.6 | |||||||||||||
| Add: Amortization of intangibles from business combinations | 7.4 | 15.6 | 22.6 | 46.7 | |||||||||||||
|
Add: Amortization of software development costs
(1)
|
12.6 | 13.2 | 36.8 | 37.9 | |||||||||||||
|
Subtotal
(2)
|
30.1 | 54.8 | 121.0 | 144.9 | |||||||||||||
|
Non-GAAP EBITDA
(2)
|
$ | 77.6 | $ | 73.1 | $ | 199.2 | $ | 191.8 | |||||||||
|
Non-GAAP EBITDA margin
(3)
|
27.6 | % | 23.9 | % | |||||||||||||
| Non-GAAP adjustments: | |||||||||||||||||
|
Add: Stock-based compensation expense
|
$ | 21.7 | $ | 21.1 | $ | 71.1 | $ | 76.4 | |||||||||
|
Add: Employee severance
|
(0.2) | — | 1.9 | — | |||||||||||||
|
Add: Acquisition and disposition-related costs
|
0.4 | 0.2 | 25.8 | 4.9 | |||||||||||||
|
Add: Security Incident-related costs
(4)
|
0.2 | 0.6 | 2.8 | 12.8 | |||||||||||||
|
Subtotal
(2)
|
22.0 | 22.0 | 101.6 | 94.1 | |||||||||||||
|
Non-GAAP adjusted EBITDA
(2)
|
$ | 99.7 | $ | 95.1 | $ | 300.8 | $ | 285.9 | |||||||||
|
Non-GAAP adjusted EBITDA margin
(5)
|
35.4 | % | 36.1 | % | |||||||||||||
|
Rule of 40
(6)
|
40.6 | % | 42.1 | % | |||||||||||||
| Non-GAAP adjusted EBITDA | $ | 99.7 | $ | 95.1 | $ | 300.8 | $ | 285.9 | |||||||||
|
Foreign currency impact on Non-GAAP adjusted EBITDA
(7)
|
(0.5) | (0.6) | (1.4) | (1.1) | |||||||||||||
|
Non-GAAP adjusted EBITDA on constant currency basis
(7)
|
$ | 99.1 | $ | 94.5 | $ | 299.4 | $ | 284.8 | |||||||||
| Non-GAAP adjusted EBITDA margin on constant currency basis | 35.4 | % | 36.1 | % | |||||||||||||
|
Rule of 40 on constant currency basis
(8)
|
40.2 | % | 41.8 | % | |||||||||||||
|
Third Quarter 2025 Form 10-Q
|
|
43
|
||||||
|
Nine months ended
September 30,
|
||||||||
| (dollars in millions) |
2025
|
2024
|
||||||
| GAAP net cash provided by operating activities | $ | 207.5 | $ | 222.4 | ||||
| GAAP operating cash flow margin | 24.9 | % | 26.1 | % | ||||
| Non-GAAP adjustments: | ||||||||
| Less: purchase of property and equipment | (4.8) | (7.2) | ||||||
| Less: capitalized software development costs | (40.3) | (42.9) | ||||||
|
Non-GAAP free cash flow
(1)
|
$ | 162.5 | $ | 172.3 | ||||
| Non-GAAP free cash flow margin | 19.5 | % | 20.2 | % | ||||
| Non-GAAP adjustments: | ||||||||
| Add: Security Incident-related cash flows | 4.3 | 15.1 | ||||||
|
Non-GAAP adjusted free cash flow
(1)
|
$ | 166.8 | $ | 187.4 | ||||
| Non-GAAP adjusted free cash flow margin | 20.0 | % | 22.0 | % | ||||
|
44
|
|
Third Quarter 2025 Form 10-Q
|
||||||
| Liquidity and Capital Resources | ||
| (dollars in millions) |
September 30,
2025 |
December 31,
2024 |
Change | ||||||||
| Cash and cash equivalents | $ | 38.3 | $ | 67.6 | (43.4) | % | |||||
| Property and equipment, net | 85.3 | 91.9 | (7.2) | % | |||||||
| Software development costs, net | 154.1 | 148.3 | 3.9 | % | |||||||
| Total carrying value of debt | 1,064.6 | 1,075.0 | (1.0) | % | |||||||
| Working capital | (290.5) | (275.5) | (5.5) | % | |||||||
|
Nine months ended September 30,
|
|||||||||||
| (dollars in millions) |
2025
|
2024
|
Change | ||||||||
| Net cash provided by operating activities | $ | 207.5 | $ | 222.4 | (6.7) | % | |||||
| Net cash used in investing activities | (57.3) | (56.3) | 1.7 | % | |||||||
| Net cash used in financing activities | (508.1) | (435.1) | 16.8 | % | |||||||
|
Third Quarter 2025 Form 10-Q
|
|
45
|
||||||
|
46
|
|
Third Quarter 2025 Form 10-Q
|
||||||
| Financial covenant | Requirement |
Ratio as of September 30, 2025
|
||||||
|
Net leverage ratio
(1)
|
≤ 3.75 to 1.00 | 2.45 to 1.00 | ||||||
| Interest coverage ratio | ≥ 2.50 to 1.00 | 6.21 to 1.00 | ||||||
|
Third Quarter 2025 Form 10-Q
|
|
47
|
||||||
| Payments due by period | |||||||||||
| (in millions) |
Less than
1 year |
More than
1 year |
Total
(1)
|
||||||||
| Recorded contractual obligations: | |||||||||||
| Debt | $ | 22.6 | $ | 1,043.2 | $ | 1,065.8 | |||||
| Operating leases | 2.0 | 5.6 | 7.6 | ||||||||
| Interest payments on debt | 0.6 | 3.1 | 3.7 | ||||||||
| Unrecorded contractual obligations: | |||||||||||
| Purchase obligations | 89.6 | 68.2 | 157.8 | ||||||||
| Interest payments on debt | 59.4 | 166.9 | 226.3 | ||||||||
|
Total contractual obligations
(1)
|
$ | 174.2 | $ | 1,287.0 | $ | 1,461.2 | |||||
|
48
|
|
Third Quarter 2025 Form 10-Q
|
||||||
| Foreign Currency Exchange Rates | ||
| Critical Accounting Policies and Estimates | ||
| Recently Issued Accounting Pronouncements | ||
|
Third Quarter 2025 Form 10-Q
|
|
49
|
||||||
| Interest Rate Risk | ||
| Foreign Currency Risk | ||
| Evaluation of Disclosure Controls and Procedures | ||
| Changes in Internal Control Over Financial Reporting | ||
|
50
|
|
Third Quarter 2025 Form 10-Q
|
||||||
|
PART II. OTHER INFORMATION | |||||||
| Issuer Purchases of Equity Securities | ||
| Period |
Total
number
of shares
purchased
(1)
|
Average
price paid per share |
Total number
of shares purchased as part of publicly announced plans or programs |
Approximate
dollar value
of shares
that may yet
be purchased
under the
plans or
programs
(in thousands)
(2)
|
|||||||||||||||||||
| Beginning balance, July 1, 2025 | $ | 544,532 | |||||||||||||||||||||
| July 1, 2025 through July 31, 2025 | — | $ | — | — | 544,532 | ||||||||||||||||||
| August 1, 2025 through August 31, 2025 | 250,069 | 64.06 | 229,000 | 529,843 | |||||||||||||||||||
| September 1, 2025 through September 30, 2025 | 230,528 | 66.99 | 230,528 | 514,399 | |||||||||||||||||||
| Total | 480,597 | $ | 65.47 | 459,528 | $ | 514,399 | |||||||||||||||||
|
Third Quarter 2025 Form 10-Q
|
|
51
|
||||||
| Trading Arrangements Adopted or Terminated | ||
| Filed In | ||||||||||||||||||||||||||||||||
|
Exhibit
Number |
Description of Document | Filed Herewith | Form | Exhibit Number | Filing Date | |||||||||||||||||||||||||||
| X | ||||||||||||||||||||||||||||||||
| X | ||||||||||||||||||||||||||||||||
| X | ||||||||||||||||||||||||||||||||
| X | ||||||||||||||||||||||||||||||||
| 101.INS | Inline XBRL Instance Document - the Instance Document does not appear in the interactive data file because its XBRL tags are embedded within the Inline XBRL Document. | X | ||||||||||||||||||||||||||||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document. | X | ||||||||||||||||||||||||||||||
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. | X | ||||||||||||||||||||||||||||||
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. | X | ||||||||||||||||||||||||||||||
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document. | X | ||||||||||||||||||||||||||||||
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. | X | ||||||||||||||||||||||||||||||
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). | X | ||||||||||||||||||||||||||||||
|
52
|
|
Third Quarter 2025 Form 10-Q
|
||||||
|
SIGNATURES | |||||||
| BLACKBAUD, INC. | |||||||||||
| Date: | November 3, 2025 | By: | /s/ Michael P. Gianoni | ||||||||
| Michael P. Gianoni | |||||||||||
| Chief Executive Officer, President and Vice Chairman of the Board | |||||||||||
| (Principal Executive Officer) | |||||||||||
| Date: | November 3, 2025 | By: | /s/ Chad M. Anderson | ||||||||
| Chad M. Anderson | |||||||||||
| Executive Vice President and Chief Financial Officer | |||||||||||
| (Principal Financial and Accounting Officer) | |||||||||||
|
Third Quarter 2025 Form 10-Q
|
|
53
|
||||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|